Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments...
Gilde Healthcare company CatalYm announces leadership changes to accelerate visugromab late-stage clinical development
Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments...
15 september 2025
Gilde Healthcare appoints Dr. Christian Stark as Group CEO of its globally operating medical technology group
The medical technology group, which includes two manufacturers of surgical instruments in the Tuttlingen region, Koscher & Würtz and Christian Diener, has appointed Dr. Christian Stark as Chief Executive Officer...
3 september 2025
Gilde Healthcare company CatalYm announces leadership changes to accelerate visugromab late-stage clinical development
Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments...
15 september 2025
Filter & zoek
Fonds strategie:
Loading...
Dit waren alle artikelen
f51c240610